Abstract
The treatment of episcleritis can usually be strictly supportive, although in some instances systemic nonsteroidal anti-inflammatory drugs (NSAIDs) are indicated. Diffuse and nodular scleritis can usually be effectively treated in the same way, that is, with NSAIDs. If NSAID therapy fails, systemic corticosteroid therapy is indicated, provided there are no contraindications to this approach. If the scleritis continues to recur with each attempt to discontinue steroid therapy after 6 months of treatment, immunomodulatory therapy (IMT) or biologic response modifiers (BRM) should be considered. The same applies for patients who develop serious steroid-induced side effects. Patients with an established, potentially lethal systemic vasculitis as the cause of scleritis (e.g., polyarteritis nodosa or granulomatosis with polyangiitis (Wegener)), and patients with necrotizing scleritis, always require treatment with IMT or BRM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Watson PG, Hazleman DL, Pavesio C, Green WR. The sclera and systemic disorders. London: Butterworth Heinemann; 2004, Chap 12. p. 291.
Lyons CJ, Hakin KN, Watson PG. Topical flurbiprofen: and effective treatment for episcleritis? Eye. 1990;4:521.
Fronert PP, Scheps FG. Long term follow up study of patients with periarteritis nodosa. Am J Med. 1967;43:8.
Fauci AS. Vasculitis. In: Parker CW, editor. Clinical Immunology. Philadelphia: W.B. Saunders; 1980. p. 473–519.
McGavin DDM, Williamson J, Forrester JV, et al. Episcleritis and scleritis. Br J Ophthalmol. 1976;60:192.
Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163.
Jones P, Jayson MIV. Rheumatoid arthritis of the eye. Proc Royal Soc Med. 1973;66:1161.
Foster CS. Nonsteroidal anti-inflammatory and immunosuppressive agents. In: Lambert DW, Potter DE, editors. Clinical ophthalmic pharmacology. Boston: Little Brown; 1987. p. 173–92.
Hemady R, Tauber J, Foster CS. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol. 1991;35:369.
McCune WJ, Golbus J, Zeldes W, et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe lupus erythematosus. N Engl J Med. 1988;318:1423.
Raizman MB, Sainz de la Maza M, Foster CS. Tectonic keratoplasty for peripheral ulcerative keratitis. Cornea. 1991;10:312.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
de la Maza, M.S., Tauber, J., Foster, C.S. (2012). Treatment of Episcleritis and Scleritis. In: The Sclera. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6502-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6502-8_9
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-6501-1
Online ISBN: 978-1-4419-6502-8
eBook Packages: MedicineMedicine (R0)